Psychedelic Research and Access in
Panama
Panama's formal access environment for classic psychedelics remains highly restrictive: public health and medicines authorities frame controlled substances within a tight medical/scientific licensing and oversight model, and the Ministry of Health continues to publish guidance and training on controlled medicines under Law 14 of 19 May 2016. In practical terms, access to psilocybin, MDMA, DMT, mescaline and related compounds appears limited to authorised research or illicit markets rather than routine clinical use.
Data updated
Key Insights
A concise view of the policy, research, access, and stakeholder details shaping psychedelic medicine inPanama.
- 1
The public record suggests a medicines-control framework that is more developed than the psychedelic research ecosystem, with emphasis on prescribing, dispensing, traceability and pharmacy supervision.
- 2
Recent ministry activity in 2026 focused on mental health coordination, but not on psychedelic access or research, which points to policy attention without a visible reform signal for classic psychedelics.
- 3
The clearest lawful pathway for classic psychedelics still appears to be authorised research rather than routine care, and I found no public Panama trial listings to suggest a local active pipeline.
- 4
Panama's controlled-medicines infrastructure is relevant for ketamine-like products, but the sources reviewed do not support a claim of public access to esketamine or any reimbursement status.
- 5
Overall, Panama looks like a low-activity jurisdiction for psychedelic medicine: restrictive regulation, some institutional capacity in health and pharmacy oversight, and no visible public clinical research footprint in the sources checked.
Research and Access Snapshot
Blossom currently tracks no country-linked psychedelic clinical trials for Panama, but the page does include 1 stakeholder.
Blossom has not linked country-level trial records yet. Treat this as a coverage gap, not proof that no local policy discussion, care, or informal activity exists.
- Active trials
- 0
- Total trials
- 0
- Stakeholders
- 1
- Events
- 0
None marked active
No linked trials
Linked organisations
No linked events
Top Compounds
Linked country trials do not show a leading compound yet.
Top Study Topics
Linked country trials do not show a leading study topic yet.
Medical Access
Panama maintains a restrictive statutory and enforcement approach to classic psychedelics (psilocybin, MDMA, DMT, mescaline, 2C-series, etc.), which remain criminalized outside of authorized research. Ketamine is an established medical anesthetic and is procured and used within the public health system; however, the proprietary esketamine nasal spray (Spravato) does not appear in public Panamanian regulator procurement/communication records and there is no publicly available evidence of national registration or public reimbursement for Spravato as of...
Regulatory Status
Panama appears to maintain a restrictive statutory and enforcement posture for classic psychedelics, with controlled substances handled under Ministry of Health oversight and older narcotics/psychotropics legislation still referenced in current guidance and training. I found no public evidence of Panama-based psilocybin or MDMA clinical trials in the sources reviewed, and no clear public indication that classic psychedelics are legally available outside authorised research; this is consistent with Blossom's access snapshot, although the exact operational position for any future trial import or compassionate-use pathway should be verified case by case.
Country Details
- Region
- North America
- Last updated
- 18 May 2026
Country Report
Medical Only (Private)Medical Access
Panama maintains a restrictive statutory and enforcement approach to classic psychedelics (psilocybin, MDMA, DMT, mescaline, 2C-series, etc.), which remain criminalized outside of authorized research. Ketamine is an established medical anesthetic and is procured and used within the public health...
Open access guide →Pro Scorecard
Country Scorecard
Compare evidence, access, payment, delivery, local ecosystem, and review confidence for Panama.
Open scorecard →Psychedelic Stakeholders in Panama
Organisations, sponsors, clinics, and research groups connected to psychedelic science in Panama.